Felicia Ekpo
Dermatology · Garland, TXNPI 1295128759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 35.4% of the total. Reporting peaked in 2024 at $419 and has fallen 55.5% since, to $186 in 2025. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 67 payments — averaging $25.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$600
- Lilly USA, LLC$173
- Sage Therapeutics, LLC$103
- Pfizer$86
- Janssen Scientific Affairs, LLC$75
- Galderma Laboratories, L.p.$73
- plus $587 from 15 others
What the payments were for
- Food & beverage$1,68399%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 19 | $600 |
| Lilly USA, LLC | 8 | $173 |
| Sage Therapeutics, LLC | 1 | $103 |
| Pfizer | 5 | $86 |
| Janssen Scientific Affairs, LLC | 1 | $75 |
| Galderma Laboratories, L.p. | 4 | $73 |
| Novo Nordisk | 4 | $72 |
| Sun Pharmaceutical Industries Inc. | 4 | $63 |
| Amgen | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Almirall LLC | 2 | $55 |
| Sanofi | 3 | $55 |
| Dermavant Sciences, Inc. | 2 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Journey Medical Corporation | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| AstraZeneca | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$100
How this compares
$1,697 in reported general payments places this provider in the 30th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 22 | $242 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Garland
- Kevin KiaGarland$271K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.